Hyunyoung Jeong
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
Publications
135
Citations
2,797
Est. group size
~5
Recurring co-author estimate
Active years
26
Publishing since 2001
Hyunyoung Jeong's research focuses on how the body and gut bacteria process drugs, including how metabolism affects drug levels, safety, and effectiveness. Recent work examines gut microbiota's role in modifying drug exposure and toxicity (e.g., for etoposide and acetaminophen), enzyme-mediated metabolism of cancer drugs like carfilzomib, and drug transport mechanisms such as P-glycoprotein's role in oral drug absorption. The group also studies related topics such as hormone levels during pregnancy and cancer treatment outcomes.
Publication output has fluctuated over the last decade, with a notable spike in 2023 followed by continued activity through 2025, suggesting an uneven but ongoing publication record rather than a steady linear trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- <b>Gut bacterial</b> <i> <b>O</b> </i> <b>-demethylation modulates systemic exposure to oral etoposide</b>
Gut Microbes · 2026
- Virtual special section: Gut microbiota in drug metabolism
Drug Metabolism and Disposition · 2026
- Role of p-glycoprotein in oral bioavailability of its substrates: Tacrolimus as a model compound.
Figshare · 2025
- Hydroxylation near the epoxyketone of carfilzomib confers protection from microsomal epoxide hydrolase-mediated metabolism
Drug Metabolism and Disposition · 2025
- 356P Adjuvant chemotherapy with or without anthracyclines in hormone receptor-positive, HER2-negative early breast cancer with intermediate to high genomic risk
Annals of Oncology · 2025
- Correction: Temporal changes in the systemic concentrations of retinoids in pregnant and postpartum women
PLoS ONE · 2024
- Phenylpropionic acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity
Gut Microbes · 2023
- Temporal changes in the systemic concentrations of retinoids in pregnant and postpartum women
PLoS ONE · 2023
- Supplementary Fig. S3 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- Supplementary Table 1 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- Supplementary Figure S1 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- Supplementary Table 3 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- Supplementary Table 5 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- Supplementary Figure S2 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- Supplementary Figure S4 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
2023
- The FASEB Journal×11
- Drug Metabolism and Disposition×8
- Drug Metabolism and Pharmacokinetics×5
- Journal of Pharmacology and Experimental Therapeutics×3
- PLoS ONE×3
- Jingheng Wang
Pharmacology, Toxicology and Pharmaceutics · The Ohio State University
- Hao Chen
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Aditi Shendre
Pharmacology, Toxicology and Pharmaceutics · The Ohio State University
- David R. Foster
Medicine · Purdue University West Lafayette
- Julie A. Johnson
Pharmacology, Toxicology and Pharmaceutics · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile